| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.92B | 67.29B | 62.13B | 52.89B | 41.85B | 38.67B |
| Gross Profit | 23.13B | 23.99B | 21.99B | 17.96B | 14.00B | 13.41B |
| EBITDA | 9.31B | 10.13B | 8.66B | 5.83B | 3.37B | 3.99B |
| Net Income | 5.35B | 6.00B | 4.97B | 3.33B | 1.91B | 1.96B |
Balance Sheet | ||||||
| Total Assets | 73.38B | 75.85B | 78.23B | 67.18B | 61.92B | 58.61B |
| Cash, Cash Equivalents and Short-Term Investments | 13.56B | 12.77B | 16.80B | 14.30B | 16.16B | 17.30B |
| Total Debt | 73.00M | 126.00M | 5.23B | 293.00M | 351.00M | 538.00M |
| Total Liabilities | 17.93B | 19.15B | 25.52B | 20.01B | 16.33B | 13.62B |
| Stockholders Equity | 55.45B | 56.69B | 52.72B | 46.95B | 45.38B | 44.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.26B | 498.00M | 947.00M | 1.34B | 1.33B |
| Operating Cash Flow | 0.00 | 4.45B | 2.74B | 1.92B | 2.02B | 3.04B |
| Investing Cash Flow | 0.00 | -1.15B | -3.78B | -1.06B | -932.00M | -2.03B |
| Financing Cash Flow | 0.00 | -7.25B | 2.80B | -2.90B | -2.83B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥115.70B | 17.28 | ― | 1.68% | 2.72% | 33.10% | |
80 Outperform | ¥51.47B | 11.75 | ― | 3.21% | 7.99% | 50.13% | |
79 Outperform | ¥105.76B | 19.22 | ― | 3.23% | 7.28% | 4.16% | |
79 Outperform | ¥57.62B | 11.67 | ― | 1.94% | -4.17% | -7.07% | |
75 Outperform | ¥86.46B | 15.40 | ― | 3.12% | 2.78% | -5.32% | |
75 Outperform | ¥36.00B | 13.52 | ― | 2.29% | 6.81% | 12.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Espec Corp. reported consolidated net sales of ¥47.1 billion for the nine months to December 31, 2025, a modest 1.7% year-on-year increase, while operating profit fell 12.9% to ¥4.28 billion and profit attributable to owners slid 13.6% to ¥3.32 billion. Despite weaker earnings, total assets and equity continued to rise, the equity ratio stayed above 74%, and the company maintained its full-year forecast, while lifting the interim dividend to ¥45 per share and targeting a total annual dividend of ¥115, signaling confidence in its balance sheet and cash-generation capacity.
Net assets climbed to ¥59.4 billion from ¥56.7 billion at the prior fiscal year-end, and net assets per share improved to ¥2,738.17, underlining an ongoing build-up of shareholder equity even as profitability softened. For the full year to March 31, 2026, Espec projects slight growth in sales to ¥68 billion and broadly flat operating profit of ¥7.6 billion, with earnings per share expected at ¥266.03, implying only a modest decline from the previous year and a continued commitment to shareholder returns through stable dividends.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen4458.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.
Espec Corp. has approved the introduction of a Stock Benefit Trust (J-ESOP) to grant company shares and equivalent cash benefits to employees in management assistant positions, linking awards to job grade and corporate performance. The scheme, modeled on the U.S. ESOP, aims to heighten employees’ awareness of contributing to medium- to long-term business performance and corporate value, and aligns with the firm’s human capital focus under its Progressive Plus 2027 plan.
Under the plan, Espec will dispose of treasury shares via a third-party allotment to a trust structure administered by Mizuho Trust & Banking and Custody Bank of Japan. The trust will hold the shares and deliver them to eligible employees who meet beneficiary requirements, with voting rights exercised per instructions from a trust administrator, reinforcing incentive alignment while managing share distribution through a controlled, ongoing trust framework.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen4458.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.
Espec Corp. has continued executing its share buyback program authorized by the board in November 2025, repurchasing 127,700 common shares on the Tokyo Stock Exchange between January 1 and January 31, 2026 for approximately ¥436 million. Cumulatively, by January 31, 2026, the company has acquired 347,600 shares for about ¥1.17 billion under the ongoing program, which allows purchases of up to 900,000 shares or ¥3.5 billion through July 31, 2026, signaling an active capital allocation policy that may support shareholder returns and enhance capital efficiency.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen3915.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.
Espec Corp. reported on the progress of its ongoing share buyback program, stating that it repurchased 131,800 common shares for a total of ¥442.4 million on the Tokyo Stock Exchange between December 1 and December 31, 2025. This transaction is part of a larger board-approved buyback framework, authorizing up to 900,000 shares or ¥3.5 billion through July 31, 2026, under which the company has cumulatively acquired 219,900 shares for ¥733.1 million as of the end of December, signaling continued efforts to optimize capital allocation and enhance shareholder value.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen3842.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.
ESPEC Corp. has announced the acquisition of 88,100 of its own shares, amounting to approximately ¥290.7 million, as part of a broader plan approved by its Board of Directors. This move is part of a strategic effort to buy back up to 900,000 shares by July 2026, potentially impacting its market position and shareholder value.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen3842.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.
Espec Corp. reported an increase in orders, particularly in its Equipment Business, but faced challenges with net sales due to long delivery lead times, affecting environmental test chambers and energy device equipment. Operating profit declined due to delayed sales and a worsening cost-of-sales ratio, leading to a decrease in profit attributable to owners. Despite these challenges, the company maintained its dividend forecast and announced a share repurchase, reflecting a commitment to shareholder returns.
The most recent analyst rating on (JP:6859) stock is a Buy with a Yen3842.00 price target. To see the full list of analyst forecasts on Espec Corp. stock, see the JP:6859 Stock Forecast page.